Hangzhou Tigermed Consulting is a contract research organisation that helps pharmaceutical, biotechnology and medical device companies develop new treatments. It provides clinical trial services, including trial design and management, data management, statistical analysis, regulatory affairs and medical writing, along with laboratory and related support work. Its customers are drug developers and healthcare companies that outsource parts of their research and development. The company is based in Hangzhou, China, and serves clients in its home market and overseas.
On this site Hangzhou Tigermed Consulting appears as a stock on the Shenzhen Stock Exchange (China), code 300347, with prices in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #501 of 2821 on the Shenzhen Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for China yet.
TrendStrong
84/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average-3.9%
From 52-week high-23.8%
MomentumFair
59/100
Typical recent returns for this exchange.
See the numbers →
3-month return3.9%
6-month return-12.3%
12-month, skipping last month-11.1%
Stability (higher is calmer)Weak
50/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)48.0%
Worst drawdown, 1 year (smaller is calmer)-45.7%
LiquidityStrong
92/100
Trades actively.
See the numbers →
Avg daily value traded930.86M CNY
Zero-volume days0.0%
IncomeWeak
40/100
Dividend is small or irregular.
See the numbers →
Dividend yield0.2%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for China when fundamentals data for this market is added. All China stocks.
52-wk range 35.47 – 67.65Daily closes, split-adjusted
Signals
50-day average53.74
200-day average52.63
Golden/death cross (60d)Golden, 13 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.84
Technical summary
Daily
Strongly bearish
2 bullish · 3 neutral · 11 bearish
Weekly
Bearish
3 bullish · 1 neutral · 8 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
54.17
Bearish
EMA 10
53.36
Bearish
SMA 20
55.70
Bearish
EMA 20
54.18
Bearish
SMA 50
53.74
Bearish
EMA 50
53.25
Bearish
SMA 100
48.95
Bullish
EMA 100
52.09
Bearish
SMA 200
52.63
Bearish
EMA 200
52.33
Bearish
Oscillators (daily)
RSI (14)
39.25
Neutral
MACD (12, 26)
-0.48
Bearish
Momentum (12)
-13.54
Bearish
Stochastic %K (14)
21.66
Neutral
Williams %R (14)
-78.34
Neutral
CCI (20)
-205.0
Bullish
Pivot points (classic, last session)
S3
45.46
S2
46.77
S1
48.67
Pivot
49.98
R1
51.88
R2
53.19
R3
55.09
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.13 CNY
Yield on today's price
0.25%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
10 Jul 2026
0.1260
17 Jun 2025
0.3000
12 Jul 2024
0.5680
7 Jul 2023
0.5500
31 May 2022
0.5000
1 Jun 2021
0.3000
22 May 2020
0.2780
1 Jul 2019
0.3500
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in CNY. Educational only, not financial advice.
